Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2966853/0/en/Allarity-Therapeutics-to-be-Granted-European-Patent-for-DRP-Companion-Diagnostic-for-Stenoparib.html
10 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/10/2961234/0/en/Allarity-Therapeutics-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html
03 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/03/2957638/0/en/Allarity-Therapeutics-Strengthens-Leadership-with-Key-Appointments-to-Accelerate-Stenoparib-PARP-Inhibitor-Program.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946589/0/en/Allarity-Therapeutics-Announces-Two-Patients-Now-Exceeding-One-Year-of-Treatment-with-Stenoparib-in-Advanced-Ovarian-Cancer-Trial.html
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2945952/0/en/Allarity-Therapeutics-Announces-New-CFO-and-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
11 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/11/2944417/0/en/Allarity-Therapeutics-Takes-Decisive-Step-Toward-Regaining-Nasdaq-Compliance-with-Nasdaq-Listing-Rule-5550-a-2.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?